Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/4439
Title: Respiratory management of infants with chronic neonatal lung disease beyond the NICU: A position statement from the Thoracic Society of Australia and New Zealand
Authors: Fitzgerald, D. A.
Kapur, N.
Nixon, G.
Robinson, P.
Massie, J.
Prentice, B.
Wilson, A.
Schilling, S.
Twiss, J.
Issue Date: 2020
Source: Aug 25, (8), 2020, p. 880-888
Pages: 880-888
Journal: Respirology
Abstract: Chronic neonatal lung disease (CNLD) is defined as continued need for any form of respiratory support (supplemental oxygen and/or assisted ventilation) beyond 36 weeks PMA. Low-flow supplemental oxygen facilitates discharge from hospital of infants with CNLD who are hypoxic in air and is widely used despite lack of evidence on the most appropriate minimum mean target oxygen saturations. Furthermore, there are minimal data to guide the home monitoring, titration or weaning of supplemental oxygen in these infants. The purpose of this position statement is to provide a guide for the respiratory management of infants with CNLD, with special emphasis on role and logistics of supplemental oxygen therapy beyond the NICU stay. Reflecting a variety of clinical practices and infant comorbidities (presence of pulmonary hypertension, retinopathy of prematurity and adequacy of growth), it is recommended that the minimum mean target range for SpO(2) during overnight oximetry to be 93-95% with less than 5% of total recording time to be below 90% SpO(2) . Safety of short-term disconnection from supplemental oxygen should be assessed before discharge, with majority of infants with CNLD not ready for discharge until supplemental oxygen requirement is ≤0.5 L/min. Sleep-time assessment of oxygenation with continuous overnight oximetry is recommended when weaning supplemental oxygen. Palivizumab is considered safe and effective for the reduction of hospital admissions with RSV infection in this group. This statement would be useful for paediatricians, neonatologists, respiratory and sleep physicians and general practitioners managing children with CNLD.1440-1843Kapur, Nitin
Orcid: 0000-0002-8423-0596
Nixon, Gillian
Robinson, Philip
Massie, John
Prentice, Bernadette
Wilson, Andrew
Schilling, Sandra
Twiss, Jacob
Fitzgerald, Dominic A
Journal Article
Respirology. 2020 Aug;25(8):880-888. doi: 10.1111/resp.13876. Epub 2020 Jun 8.
DOI: 10.1111/resp.13876
Keywords: New Zealand;Oximetry;Oxygen/metabolism;Oxygen Inhalation Therapy;Patient Discharge;*Respiration;Sleep;Treatment Outcome;Infant, Newborn;*oximetry;*oxygen;*palivizumab;*premature infant;AustraliaHumans;*bronchopulmonary dysplasia;Infant, Newborn, Diseases/epidemiology/physiopathology/*therapy;*Intensive Care Units, Neonatal;Lung Diseases/epidemiology/physiopathology/*therapy
Type: Article
Appears in Sites:Children's Health Queensland Publications

Show full item record

Page view(s)

66
checked on Feb 12, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.